AZD2624 blocks neurokinin 3 receptors, reducing hot flush frequency without hormone replacement risks.
Dendropanax morbifera extracts activate estrogen receptors, offering a safer alternative to synthetic hormone replacement therapy.
Double-stranded RNA agents degrade IGFALS and IGF-1 mRNA transcripts, reducing side effects from receptor antagonism in acromegaly treatment.
Administering a FAK inhibitor converts acinar cells into insulin-producing beta-cells, restoring glucose regulation without continuous medication.
Eurycoma longifolia extract normalizes FSH and LH concentrations, offering a safer alternative to synthetic hormone replacement therapy.